Health Policy Expert Peter Bach, MD, Goes to Biotech Company Health Policy Expert Peter Bach, MD, Goes to Biotech Company

A fierce critic of drug costs, Peter Bach, MD, has left academia for a small biotech company working on liquid biopsy for lung cancer.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news